The FGF family: biology, pathophysiology and therapy.

The FGF family: biology, pathophysiology and therapy.
复制标题

DOI:
10.1038/nrd2792
复制
发表时间:
2009-03
期刊:
Nature reviews. Drug discovery
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

成纤维细胞生长因子(FGF)家族调控众多发育过程,包括脑模式形成、分支形态发生和肢体发育。FGF的一些促有丝分裂、细胞保护和血管生成的治疗应用已经在探索中,并且内分泌作用的FGF19亚家族在胆汁酸、葡萄糖和磷酸盐内稳态中关键作用的最新发现,引发了对该家族药理潜力的新兴趣。本综述讨论了重组FGF和小分子FGF受体激酶抑制剂在癌症和心血管疾病治疗中的传统应用,以及它们在代谢综合征和低磷血症疾病治疗中新兴的潜力。
The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.
正常受试者和新诊断 2 型糖尿病患者的循环 FGF-21 水平
DOI: 10.1055/s-2007-985148
发表时间: 2008-01-01
影响因子: 1.8
作者:
Chen, W. -W.;Li, L.;Boden, G.
通讯作者: Boden, G.
DOI: 10.1016/j.cmet.2007.05.002
发表时间: 2007-06-01
期刊: CELL METABOLISM
影响因子: 29
作者:
Badman, Michael K.;Pissios, Pavlos;Maratos-Flier, Eleftheria
通讯作者: Maratos-Flier, Eleftheria
DOI: 10.1016/j.biocel.2005.10.017
发表时间: 2006-01-01
影响因子: 4
作者:
Abuharbeid, Shaker;Czubayko, Frank;Aigner, Achim
通讯作者: Aigner, Achim
DOI: 10.1177/00912700122010230
发表时间: 2001-04-01
影响因子: 2.9
作者:
Bush, MA;Samara, E;Chronos, NA
通讯作者: Chronos, NA
DOI: 10.1097/01.brs.0000131217.61390.2c
发表时间: 2004-07-15
期刊: SPINE
影响因子: 3
作者:
Cheng, H;Liao, KK;Shih, YH
通讯作者: Shih, YH